>
Switch to:

BridgeBio Pharma Net Margin %

: -1,425.61% (As of Sep. 2020)
View and export this data going back to 2019. Start your Free Trial

Net margin is calculated as Net Income divided by its Revenue. BridgeBio Pharma's Net Income for the three months ended in Sep. 2020 was $-115.86 Mil. BridgeBio Pharma's Revenue for the three months ended in Sep. 2020 was $8.13 Mil. Therefore, BridgeBio Pharma's net margin for the quarter that ended in Sep. 2020 was -1,425.61%.

NAS:BBIO' s Net Margin % Range Over the Past 10 Years
Min: -1832.68   Med: -642.47   Max: -642.47
Current: -1832.68

-1832.68
-642.47

NAS:BBIO's Net Margin % is ranked lower than
79% of the 929 Companies
in the Biotechnology industry.

( Industry Median: -191.41 vs. NAS:BBIO: -1832.68 )

BridgeBio Pharma Net Margin % Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

BridgeBio Pharma Annual Data
Dec17 Dec18 Dec19
Net Margin % 0.00 0.00 -642.47

BridgeBio Pharma Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Net Margin % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -224.30 -531.57 0.00 0.00 -1,425.61

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


BridgeBio Pharma Net Margin % Distribution

* The bar in red indicates where BridgeBio Pharma's Net Margin % falls into.



BridgeBio Pharma Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

BridgeBio Pharma's Net Margin for the fiscal year that ended in Dec. 2019 is calculated as

Net Margin=Net Income (A: Dec. 2019 )/Revenue (A: Dec. 2019 )
=-260.587/40.56
=-642.47 %

BridgeBio Pharma's Net Margin for the quarter that ended in Sep. 2020 is calculated as

Net Margin=Net Income (Q: Sep. 2020 )/Revenue (Q: Sep. 2020 )
=-115.859/8.127
=-1,425.61 %

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


BridgeBio Pharma  (NAS:BBIO) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


BridgeBio Pharma Net Margin % Related Terms


BridgeBio Pharma Net Margin % Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)